Spectrum Pharmaceuticals Inc. (SPPI) announced Tuesday that the interim data from ... Shares finished with a gain of 5.21 at $19.67 on the highest volume of the year. The stock broke out of over a 2-week trading range and set a new …
Spectrum Pharmaceuticals, Inc. SPPI was a big mover last session, as the company saw its shares jump a little above 22% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. …
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully ... of approximately $11.3 million and will issue 3 million shares of its common stock in exchange for the cancellation of all of the outstanding …
Rommel M. Leuterio, president and COO of SPPI, said that while both firms were highly qualified to list on the Philippine Stock Exchange now, they opted to wait for a more opportune time to enable investors to see the company’s sustained …
ticker=SPPI ZIOPHARM Oncology Inc. https://rdinvesting.com/news/?ticker=ZIOP Spectrum Pharmaceuticals stock
Spectrum Pharmaceuticals Inc. (SPPI) Gained 36.03% to close Wednesday's (Oct.18 ... We alerted our premium subscribers to this stock on October 3, 2017 when it was trading around $14. 2. Endocyte Inc. (ECYT) Gained 12.87% …
CASI's product pipeline features (1) EVOMELA ®, MARQIBO ®, ZEVALIN ®, all U.S. Food and Drug Administration (FDA) approved drugs in-licensed from Spectrum Pharmaceuticals, Inc. for China regional ... price of our common stock; …
... Inc. (SPPI) on Tuesday reported a loss of $23 million in its first quarter. On a per-share basis, the Henderson, Nevada-based company said it had a loss of 29 cents. Losses, adjusted for amortization costs and stock option expense, were …
Yahoo!9mon